File Download
Patent History
- ApplicationUS 12/4171228 2014-02-03
- PublicationUS 20150218193 2015-08-06
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
Patent: Water-Soluble Derivatives and Prodrugs of Acacetin and Methods of Making and Using Thereof
| Title | Water-Soluble Derivatives and Prodrugs of Acacetin and Methods of Making and Using Thereof |
|---|---|
| Priority Date | 2014-02-03 US 12/4171228 |
| Inventors | |
| Issue Date | 2015 |
| Citation | US Published patent application US 20150218193. Washington, DC: US Patent and Trademark Office (USPTO), 2015 How to Cite? |
| Abstract | Water-soluble derivatives and/or prodrugs of acacetin are described herein. The compounds can be used as cardioprotection agents against myocardial infarction induced by ischemia-reperfusion. In one embodiment the compounds are used to treat ischemic cardiac diseases. In the preferred embodiment, the compounds are used to treat and/or prevent myocardial infarction in humans. |
| Persistent Identifier | http://hdl.handle.net/10722/221223 |
| References |
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2015-11-05T03:51:28Z | - |
| dc.date.available | 2015-11-05T03:51:28Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | US Published patent application US 20150218193. Washington, DC: US Patent and Trademark Office (USPTO), 2015 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/221223 | - |
| dc.description.abstract | Water-soluble derivatives and/or prodrugs of acacetin are described herein. The compounds can be used as cardioprotection agents against myocardial infarction induced by ischemia-reperfusion. In one embodiment the compounds are used to treat ischemic cardiac diseases. In the preferred embodiment, the compounds are used to treat and/or prevent myocardial infarction in humans. | - |
| dc.title | Water-Soluble Derivatives and Prodrugs of Acacetin and Methods of Making and Using Thereof | - |
| dc.type | Patent | - |
| dc.identifier.authority | LI GUI-RONG=rp00476 | - |
| dc.description.nature | published_or_final_version | - |
| dc.contributor.inventor | LI GUI-RONG | - |
| dc.contributor.inventor | LIN FENG | - |
| patents.identifier.application | US 12/4171228 | - |
| patents.description.assignee | SHANGHAI INST PHARM INDUSTRY [CN]; VERSITECH LTD [CN] | - |
| patents.description.country | United States of America | - |
| patents.date.publication | 2015-08-06 | - |
| dc.relation.references | US 2008214493 (A1) 2008-09-04 | - |
| dc.relation.references | U S7816400 (B2) 2010-10-19 | - |
| dc.relation.references | US 2010331271 (A1) 2010-12-30 | - |
| dc.relation.references | U S8461198 (B2) 2013-06-11 | - |
| dc.relation.references | WO 2014134419 (A1) 2014-09-04 | - |
| patents.identifier.hkutechid | Medi-2014-00505-1 | - |
| patents.date.application | 2014-02-03 | - |
| patents.date.priority | 2014-02-03 US 12/4171228 | - |
| patents.description.cc | us | - |
| patents.identifier.publication | US 20150218193 | - |
| patents.relation.family | CN 104817592 (A) 2015-08-05 | - |
| patents.relation.family | EP 2902399 (A1) 2015-08-05 | - |
| patents.description.kind | A1 | - |